The use of the proximal 3′ss in SREK1 leads to a premature terminating codon (PTC) (Figure 8A), which would most likely mean an unstable transcript or protein and decreased SREK1 activity in the tumor would be predicted. The gene discussed is SREK1; the disease is neoplasm.